International Journal of Medical Laboratory Research (IJMLR)

CLINICOHEMATOLOGICAL PROFILES OF HEPATITIS B VIRUS (HBV): OBSERVATIONS FROM A TERTIARY CARE CENTRE

 

RP Jakribettu, T George, A Challapalli, M S Baliga

 

ABSTRACT: Aim: In humans, Hepatitis B virus(HBV) is arguably the most common organ specific virus affecting the liver. The pathological sequelae and stages especially in the liver are well studied. However reports on the effect of HBV on the extrahepatic organs are lacking. The present study was carried out to ascertain clinical presentations and the alterations on the haematological and hepatic parameters. Material and Methods: This was a retrospective study and was conducted in a tertiary care hospital in India. Data was collected and analyzed in people who were confirmed to be affected only by HBV by the standard diagnostic method using the HB surface Antigen (HBsAg) for the period January 2016 to December 2016. Results: The results indicated that during the study period, a total of 233 people were included in the study and compared with healthy individuals who were coming for regular health check up and were tested negative for any infectious and chronic diseases. Of these 46 were symptomatic, while 187 were asymptomatic and were diagnosed incidentally during routine/mandatory investigation before surgery. In the 46 symptomatic patient’s fever (73.91%), jaundice (63.04%), loss of appetite (39.12%), nausea & vomiting (52.17%), fatigue (28.26%), abdominal pain (17.39%) and Ascites (8.69%) were seen. There was a significant difference in the various haematological, hepatic and electrolyte endpoints (p < 0.05 to 0.0001). Conclusion: The study indicates that acute infection with HBV causes changes in the alterations in haematological, hepatic and electrolytes in the serum.

 

KEY WORDS: Hepatitis B Virus (HBV); clinical, haematological, electrolytes.

​

REFERENCES:

1. Souza B F, Drexler J F, Lima R S, Rosário Mde O, Netto E M. Theories about evolutionary origins of human hepatitis B virus in primates and humans. Braz J Infect Dis. 2014; 18(5):535-43.

2. Peng H, Li Y, Liu Y et al: HBx and SP1 upregulate DKK1 expression. Acta Biochim Pol. 2017; 64(1):35-39.

3. Masatoshi Ishigami, Yasuhiro Ogura, YoshikiHirooka, and HidemiGotoChange of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol. 2015 Sep 28; 21(36): 10290–10298.

4. Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 1996; 38(Suppl 2):S18-23.

5. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 10th edition volume-2; 1309-29.

6. Halle MP, Choukem SP, Kaze FF et al, Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon. Iran J Kidney Dis. 2016; 10(5):304-309.

7. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology. 2007;45:1056–1075.

8. Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology.2009;137:1593–608.e1-2

9. Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: Recent advances. J GastroenterolHepatol 2011; 26(Suppl 1):123-30.

10. Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men. J Natl Cancer Inst 2005; 97:265-72.

11. Liaw YF, Tsai SL, Sheen IS, et al. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am J Gastroenterol 1998; 93:354

12. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005; 25(Suppl 1):3-8.

13. Heyson C. H. Chan, Vincent W. S. Wong, Grace L. H. Wong, Whitney Tang, Justin C. Y. Wu and Siew C. Ng.Prevalence of hepatitis B and clinical outcomes in inflammatory bowel disease patients in a viral-endemic region; . BMC Gastroenterology (2016) 16:100

14. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003; 23:47-58.

15. Hoofnagle JH, Schafer DF. Serologic markers of hepatitis B virus infection. Semin Liver Dis 1986; 6:1-10.

16. Chu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002; 36:1408-15.

17. Sharma SK, Saini N, Chwla Y. Hepatitis B virus: inactive carriers. Virol J. 2005; 2:82. doi: 10.1186/1743-422X-2-82 PMID: 16191199;

18. Birajdar SV, Chavan SS, Mundhe SA, Bhosale MG. Clinical and biochemical profile of patients with viral hepatitis at tertiary care centre. Int J Adv Med 2017;4:412-6.

19. Jain P, Prakash S, Gupta S, Singh KP, Shrivastava S, Singh DD, et al. Prevalence of hepatitis A virus, hepatitis B virus, hepatitis C virus, hepatitis D virus and hepatitis E virus as causes of acute viral hepatitis in North India: A hospital based study. Indian J Med Microbiol 2013;31:261-5.

20. Singh K, Farooq U, Singh S, Bharti AK, Kaur N, Shariq M. Hepatitis B- and Hepatitis C-infected Cases and Their Correlation with Liver Function Test in Teerthanker Mahaveer Medical College & Research Centre, Moradabad, Uttar Pradesh India. Int J Sci Stud 2016; 4(1):16-20.